Comparison

Anrukinzumab European Partner

€767.00
Excl. VAT
Item no. HY-P99439-5mg
Manufacturer MedChem Express
CASRN 910649-32-0
Amount 5 mg
Category
Type Inhibitor
Specific against other
Purity 98.64
Dry ice Yes
Citations [1]Bree A, et al. IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. J Allergy Clin Immunol. 2007 May;119(5):1251-7.
[2]Reinisch W, et al. Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study. Gut. 2015 Jun;64(6):894-900.
[3]Elias JA, et al. IL-13 in asthma. The successful integration of lessons from mice and humans. Am J Respir Crit Care Med. 2011 Apr 15;183(8):957-8.
Smiles [Anrukinzumab]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias IMA-638
Available
Product Description
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma[1][2][3].
StorageTemperature
Store at -80°C for 2 years
Shipping
Dry Ice
Molecular Weight
N/A
Clinical Information
Phase 2
Solubility
10 mM in DMSO
Pathway
Immunology/Inflammation
Manufacturers Product type
Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
Listprice: €767.00
Price: €767.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close